Patents Assigned to Node Pharma AS
  • Publication number: 20240091391
    Abstract: The present invention relates to MOFs for use in radiotherapy. More particularly, the invention provides a particle comprising a MOF, optionally at least one targeting moiety and at least one radionuclide; a composition comprising said particle; said particle or composition for use as a medicament; said particle or composition for use in a method for the treatment of a proliferative disease; said particle or composition for use in a method for the treatment of a chronic inflammatory disease; and a kit comprising a particle comprising a MOF, an optional targeting moiety, and a radionuclide cation.
    Type: Application
    Filed: October 27, 2023
    Publication date: March 21, 2024
    Applicant: Node Pharma AS
    Inventors: Sigurd ØIEN-ØDEGAARD, Erik MJÅLAND